News/ News/ Oncology Ipsen adds Blueprint’s FOP rare disease drug to pipeline for $535m Richard Staines Blueprint Medicines, FOP, Ipsen, M&A, R&D, Rare diseases 0 Comment Ipsen has added to its rare diseases pipeline after striking an agreement with US biotech Blueprint for a Share X Ipsen adds Blueprint’s FOP rare disease drug to pipeline for $535m https://pharmaphorum.com/news/ipsen-adds-blueprints-fop-rare-disease-drug-to-pipeline-for-535m/
Blueprint Medicines, FOP, Ipsen, M&A, R&D, Rare diseases
0 Comment
